an3ca Search Results


an3  (ATCC)
96
ATCC an3
An3, supplied by ATCC, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/an3/product/ATCC
Average 96 stars, based on 1 article reviews
an3 - by Bioz Stars, 2026-03
96/100 stars
  Buy from Supplier
atcc htb 17  (ATCC)
93
ATCC atcc htb 17
Atcc Htb 17, supplied by ATCC, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/atcc htb 17/product/ATCC
Average 93 stars, based on 1 article reviews
atcc htb 17 - by Bioz Stars, 2026-03
93/100 stars
  Buy from Supplier
an3ca  (DSMZ)
91
DSMZ an3ca
CDK9 expression in endometrial cancer cell lines. (A) Expression levels of CDK9 in endometrial cancer cell lines <t>(AN3CA,</t> ARK-2, HEC-1A, HEC-1B, lshikawa, RL95-2 and SPAC1S) as determined by western blotting. (B) Relative expression of CDK9 and α-tubulin in the endometrial cancer cell lines. CDK9, cyclin-dependent kinase 9.
An3ca, supplied by DSMZ, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/an3ca/product/DSMZ
Average 91 stars, based on 1 article reviews
an3ca - by Bioz Stars, 2026-03
91/100 stars
  Buy from Supplier
an3ca  (CLS Cell Lines Service GmbH)
90
CLS Cell Lines Service GmbH an3ca
CDK9 expression in endometrial cancer cell lines. (A) Expression levels of CDK9 in endometrial cancer cell lines <t>(AN3CA,</t> ARK-2, HEC-1A, HEC-1B, lshikawa, RL95-2 and SPAC1S) as determined by western blotting. (B) Relative expression of CDK9 and α-tubulin in the endometrial cancer cell lines. CDK9, cyclin-dependent kinase 9.
An3ca, supplied by CLS Cell Lines Service GmbH, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/an3ca/product/CLS Cell Lines Service GmbH
Average 90 stars, based on 1 article reviews
an3ca - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
an3ca lysate  (Santa Cruz Biotechnology)
92
Santa Cruz Biotechnology an3ca lysate
CDK9 expression in endometrial cancer cell lines. (A) Expression levels of CDK9 in endometrial cancer cell lines <t>(AN3CA,</t> ARK-2, HEC-1A, HEC-1B, lshikawa, RL95-2 and SPAC1S) as determined by western blotting. (B) Relative expression of CDK9 and α-tubulin in the endometrial cancer cell lines. CDK9, cyclin-dependent kinase 9.
An3ca Lysate, supplied by Santa Cruz Biotechnology, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/an3ca lysate/product/Santa Cruz Biotechnology
Average 92 stars, based on 1 article reviews
an3ca lysate - by Bioz Stars, 2026-03
92/100 stars
  Buy from Supplier
hec-1b endometrial cancer cells  (China Center for Type Culture Collection)
90
China Center for Type Culture Collection hec-1b endometrial cancer cells
CDK9 expression in endometrial cancer cell lines. (A) Expression levels of CDK9 in endometrial cancer cell lines <t>(AN3CA,</t> ARK-2, HEC-1A, HEC-1B, lshikawa, RL95-2 and SPAC1S) as determined by western blotting. (B) Relative expression of CDK9 and α-tubulin in the endometrial cancer cell lines. CDK9, cyclin-dependent kinase 9.
Hec 1b Endometrial Cancer Cells, supplied by China Center for Type Culture Collection, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/hec-1b endometrial cancer cells/product/China Center for Type Culture Collection
Average 90 stars, based on 1 article reviews
hec-1b endometrial cancer cells - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
an3ca  (Charles River Laboratories)
90
Charles River Laboratories an3ca
CDK9 expression in endometrial cancer cell lines. (A) Expression levels of CDK9 in endometrial cancer cell lines <t>(AN3CA,</t> ARK-2, HEC-1A, HEC-1B, lshikawa, RL95-2 and SPAC1S) as determined by western blotting. (B) Relative expression of CDK9 and α-tubulin in the endometrial cancer cell lines. CDK9, cyclin-dependent kinase 9.
An3ca, supplied by Charles River Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/an3ca/product/Charles River Laboratories
Average 90 stars, based on 1 article reviews
an3ca - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
human endometrial carcinoma cell lines an3ca  (Fuxiang Biotechnology Co Ltd)
90
Fuxiang Biotechnology Co Ltd human endometrial carcinoma cell lines an3ca
CDK9 expression in endometrial cancer cell lines. (A) Expression levels of CDK9 in endometrial cancer cell lines <t>(AN3CA,</t> ARK-2, HEC-1A, HEC-1B, lshikawa, RL95-2 and SPAC1S) as determined by western blotting. (B) Relative expression of CDK9 and α-tubulin in the endometrial cancer cell lines. CDK9, cyclin-dependent kinase 9.
Human Endometrial Carcinoma Cell Lines An3ca, supplied by Fuxiang Biotechnology Co Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/human endometrial carcinoma cell lines an3ca/product/Fuxiang Biotechnology Co Ltd
Average 90 stars, based on 1 article reviews
human endometrial carcinoma cell lines an3ca - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
ec cells (kle, an3 ca, hec-1-b, rl95-2, ishikawa (ik), icell, shanghai  (iCell Gene Therapeutics)
90
iCell Gene Therapeutics ec cells (kle, an3 ca, hec-1-b, rl95-2, ishikawa (ik), icell, shanghai
CDK9 expression in endometrial cancer cell lines. (A) Expression levels of CDK9 in endometrial cancer cell lines <t>(AN3CA,</t> ARK-2, HEC-1A, HEC-1B, lshikawa, RL95-2 and SPAC1S) as determined by western blotting. (B) Relative expression of CDK9 and α-tubulin in the endometrial cancer cell lines. CDK9, cyclin-dependent kinase 9.
Ec Cells (Kle, An3 Ca, Hec 1 B, Rl95 2, Ishikawa (Ik), Icell, Shanghai, supplied by iCell Gene Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/ec cells (kle, an3 ca, hec-1-b, rl95-2, ishikawa (ik), icell, shanghai/product/iCell Gene Therapeutics
Average 90 stars, based on 1 article reviews
ec cells (kle, an3 ca, hec-1-b, rl95-2, ishikawa (ik), icell, shanghai - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
an3ca  (iCell Bioscience Inc)
90
iCell Bioscience Inc an3ca
CDK9 expression in endometrial cancer cell lines. (A) Expression levels of CDK9 in endometrial cancer cell lines <t>(AN3CA,</t> ARK-2, HEC-1A, HEC-1B, lshikawa, RL95-2 and SPAC1S) as determined by western blotting. (B) Relative expression of CDK9 and α-tubulin in the endometrial cancer cell lines. CDK9, cyclin-dependent kinase 9.
An3ca, supplied by iCell Bioscience Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/an3ca/product/iCell Bioscience Inc
Average 90 stars, based on 1 article reviews
an3ca - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
an3ca  (Procell Inc)
90
Procell Inc an3ca
CDK9 expression in endometrial cancer cell lines. (A) Expression levels of CDK9 in endometrial cancer cell lines <t>(AN3CA,</t> ARK-2, HEC-1A, HEC-1B, lshikawa, RL95-2 and SPAC1S) as determined by western blotting. (B) Relative expression of CDK9 and α-tubulin in the endometrial cancer cell lines. CDK9, cyclin-dependent kinase 9.
An3ca, supplied by Procell Inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/an3ca/product/Procell Inc
Average 90 stars, based on 1 article reviews
an3ca - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier
endometrial adenocarcinoma an3-ca  (Human Protein Atlas)
90
Human Protein Atlas endometrial adenocarcinoma an3-ca
TRAP1 expression levels in different tissue or cell types, either normal (upper panel) or transformed (lower panel)
Endometrial Adenocarcinoma An3 Ca, supplied by Human Protein Atlas, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/endometrial adenocarcinoma an3-ca/product/Human Protein Atlas
Average 90 stars, based on 1 article reviews
endometrial adenocarcinoma an3-ca - by Bioz Stars, 2026-03
90/100 stars
  Buy from Supplier

Image Search Results


CDK9 expression in endometrial cancer cell lines. (A) Expression levels of CDK9 in endometrial cancer cell lines (AN3CA, ARK-2, HEC-1A, HEC-1B, lshikawa, RL95-2 and SPAC1S) as determined by western blotting. (B) Relative expression of CDK9 and α-tubulin in the endometrial cancer cell lines. CDK9, cyclin-dependent kinase 9.

Journal: Oncology Reports

Article Title: Targeting CDK9: A novel biomarker in the treatment of endometrial cancer

doi: 10.3892/or.2020.7746

Figure Lengend Snippet: CDK9 expression in endometrial cancer cell lines. (A) Expression levels of CDK9 in endometrial cancer cell lines (AN3CA, ARK-2, HEC-1A, HEC-1B, lshikawa, RL95-2 and SPAC1S) as determined by western blotting. (B) Relative expression of CDK9 and α-tubulin in the endometrial cancer cell lines. CDK9, cyclin-dependent kinase 9.

Article Snippet: AN3CA was obtained from the German Collection of Microorganisms and Cell Cultures (DSMZ; Braunschweig, Germany).

Techniques: Expressing, Western Blot

CDK9 knockdown by siRNA transfection suppresses endometrial cancer cell proliferation. (A and B) MTT assay revealed significant dose-dependent inhibition of cell proliferation after CDK9 siRNA treatment. **P<0.01 compared with the cell only control group. (C and D) Expression levels of CDK9 and related signaling pathway proteins involved in transcription and apoptosis after transfection of CDK9 siRNA and nonspecific siRNA (NC siRNA) in AN3CA and SPAC1S cell lines by western blot analysis. CDK9, cyclin-dependent kinase 9; Mcl-1, myeloid cell leukemia-1; Bax, proapoptotic protein BCL2 associated X, apoptosis regulator.

Journal: Oncology Reports

Article Title: Targeting CDK9: A novel biomarker in the treatment of endometrial cancer

doi: 10.3892/or.2020.7746

Figure Lengend Snippet: CDK9 knockdown by siRNA transfection suppresses endometrial cancer cell proliferation. (A and B) MTT assay revealed significant dose-dependent inhibition of cell proliferation after CDK9 siRNA treatment. **P<0.01 compared with the cell only control group. (C and D) Expression levels of CDK9 and related signaling pathway proteins involved in transcription and apoptosis after transfection of CDK9 siRNA and nonspecific siRNA (NC siRNA) in AN3CA and SPAC1S cell lines by western blot analysis. CDK9, cyclin-dependent kinase 9; Mcl-1, myeloid cell leukemia-1; Bax, proapoptotic protein BCL2 associated X, apoptosis regulator.

Article Snippet: AN3CA was obtained from the German Collection of Microorganisms and Cell Cultures (DSMZ; Braunschweig, Germany).

Techniques: Knockdown, Transfection, MTT Assay, Inhibition, Control, Expressing, Western Blot

CDK9 inhibitor reduces endometrial cancer cell proliferation by suppressing transcription elongation and inducing apoptosis in endometrial cancer cells. (A and B) Relative cell viability of AN3CA and SPAC1S cells after exposure to different concentrations of the CDK9 inhibitor LDC067 for 5 days. **P<0.01 compared with the lowest concentration group (1×10 −3 µM). (C and D) Expression levels of CDK9 and related signaling pathway proteins involved in transcription and apoptosis after treatment with LDC067 in cells by western blot analysis. CDK9, cyclin-dependent kinase 9; Mcl-1, myeloid cell leukemia-1; Bax, proapoptotic protein BCL2 associated X, apoptosis regulator; PARP, poly(ADP-ribose) polymerase.

Journal: Oncology Reports

Article Title: Targeting CDK9: A novel biomarker in the treatment of endometrial cancer

doi: 10.3892/or.2020.7746

Figure Lengend Snippet: CDK9 inhibitor reduces endometrial cancer cell proliferation by suppressing transcription elongation and inducing apoptosis in endometrial cancer cells. (A and B) Relative cell viability of AN3CA and SPAC1S cells after exposure to different concentrations of the CDK9 inhibitor LDC067 for 5 days. **P<0.01 compared with the lowest concentration group (1×10 −3 µM). (C and D) Expression levels of CDK9 and related signaling pathway proteins involved in transcription and apoptosis after treatment with LDC067 in cells by western blot analysis. CDK9, cyclin-dependent kinase 9; Mcl-1, myeloid cell leukemia-1; Bax, proapoptotic protein BCL2 associated X, apoptosis regulator; PARP, poly(ADP-ribose) polymerase.

Article Snippet: AN3CA was obtained from the German Collection of Microorganisms and Cell Cultures (DSMZ; Braunschweig, Germany).

Techniques: Concentration Assay, Expressing, Western Blot

Inhibition of CDK9 suppresses endometrial cancer cell colony formation. (A) Representative images of endometrial cancer cell colony formation after incubation with different concentrations of LDC067 (0, 2.5, 5.0, and 10 µM) for 14 days. (B and C) Quantification of clonogenicity formation of AN3CA (B) and SPAC1S (C) cells after LDC067 treatment. **P<0.01 compared with the Cell only group. CDK9, cyclin-dependent kinase 9.

Journal: Oncology Reports

Article Title: Targeting CDK9: A novel biomarker in the treatment of endometrial cancer

doi: 10.3892/or.2020.7746

Figure Lengend Snippet: Inhibition of CDK9 suppresses endometrial cancer cell colony formation. (A) Representative images of endometrial cancer cell colony formation after incubation with different concentrations of LDC067 (0, 2.5, 5.0, and 10 µM) for 14 days. (B and C) Quantification of clonogenicity formation of AN3CA (B) and SPAC1S (C) cells after LDC067 treatment. **P<0.01 compared with the Cell only group. CDK9, cyclin-dependent kinase 9.

Article Snippet: AN3CA was obtained from the German Collection of Microorganisms and Cell Cultures (DSMZ; Braunschweig, Germany).

Techniques: Inhibition, Incubation

Inhibition of CDK9 reduces endometrial cancer cell migration. (A and B) Representative images of AN3CA and SPAC1S cell migration after CDK9 inhibitor LDC067 treatment for 0, 24, and 48 h. (C and D) Quantification of cell migration distance of AN3CA and SPAC1S cells after LDC067 treatment. **P<0.01 compared with the Cell only group. CDK9, cyclin-dependent kinase 9.

Journal: Oncology Reports

Article Title: Targeting CDK9: A novel biomarker in the treatment of endometrial cancer

doi: 10.3892/or.2020.7746

Figure Lengend Snippet: Inhibition of CDK9 reduces endometrial cancer cell migration. (A and B) Representative images of AN3CA and SPAC1S cell migration after CDK9 inhibitor LDC067 treatment for 0, 24, and 48 h. (C and D) Quantification of cell migration distance of AN3CA and SPAC1S cells after LDC067 treatment. **P<0.01 compared with the Cell only group. CDK9, cyclin-dependent kinase 9.

Article Snippet: AN3CA was obtained from the German Collection of Microorganisms and Cell Cultures (DSMZ; Braunschweig, Germany).

Techniques: Inhibition, Migration

TRAP1 expression levels in different tissue or cell types, either normal (upper panel) or transformed (lower panel)

Journal: Trends in cell biology

Article Title: Mitochondrial oxidative phosphorylation TRAP(1)ped in tumor cells

doi: 10.1016/j.tcb.2014.03.005

Figure Lengend Snippet: TRAP1 expression levels in different tissue or cell types, either normal (upper panel) or transformed (lower panel)

Article Snippet: Endometrial adenocarcinoma: AN3-CA , Medium (IHC) , The Human Protein Atlas.

Techniques: Expressing, Transformation Assay, Real-time Polymerase Chain Reaction